首页> 外文期刊>Journal of Cancer Research and Therapeutics >The clinical and pathological features affecting the time of relapse in patients with early stage colorectal cancer
【24h】

The clinical and pathological features affecting the time of relapse in patients with early stage colorectal cancer

机译:影响早期结直肠癌患者复发时间的临床和病理特征

获取原文
       

摘要

Background: The relapses of colorectal cancer (CRC) frequently occur in 2 years period after the time of diagnosis. However, a considerable proportion of patients relapse in the late period. Aim: The aim of the present study is to define the factors predicting the early and late relapses of patients with early stage CRC. Materials and Methods: A total of 250 patients with CRC, who relapsed after completion of primary therapy between 2005 and 2014, were enrolled in the study. According to the time of relapse, patients were divided into two groups as follows: Early relapse (Group 1: Within first 24 months) and late relapse (Group 2: Later than 24 months). Clinicopathological features and survival rates of the two groups were compared. Results: Of 250 patients, 151 (60.4%) (Group 1) were relapsed within the first 24 months after completion of the primary therapy and 105 (39.6%) were relapsed later than 24 months. The patients with T1–T2 and Grade I tumors were relapsed in late period (P P = 0.05). Conclusions: In patients with CRC, the time duration of relapse after completion of the operation and adjuvant chemotherapy was a prognostic factor. Grade I and superficial tumors (T1–T2) are the predictors of late relapses (after >24 months). The patients relapsed within the first 24 months after primary therapy had poor prognosis compared to those who relapsed in late period.
机译:背景:大肠癌(CRC)的复发通常在诊断后的2年内发生。但是,相当一部分患者在晚期复发。目的:本研究的目的是确定预测早期CRC患者早期和晚期复发的因素。资料与方法:纳入2005年至2014年完成初治后复发的250例CRC患者。根据复发时间,将患者分为两组:早期复发(第1组:在最初的24个月内)和晚期复发(第2组:在24个月后)。比较两组的临床病理特征和生存率。结果:250例患者中,151例(60.4%)(第1组)在完成主要治疗后的前24个月内复发,105例(39.6%)在24个月后复发。患有T1-T2和I级肿瘤的患者在晚期复发(P P = 0.05)。结论:在CRC患者中,手术完成和辅助化疗后复发的持续时间是预后因素。 I级和浅表肿瘤(T1-T2)是晚期复发(> 24个月后)的预测指标。与晚期复发者相比,初次治疗后24个月内复发的患者预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号